PharmTech Drug Digest 11.20
News|Articles|September 26, 2017

PTSM: Pharmaceutical Technology Sourcing and Management

  • PTSM: Pharmaceutical Technology Sourcing and Management-10-04-2017
  • Volume 12
  • Issue 10

Software Adds Data Integrity Functions

New algorithm and functions in Shimadzu’s LabSolutions software enable compliance with data integrity regulations.

The updated LabSolutions analytical data system from Shimadzu incorporates supplementary functions to comply with data integrity regulations and to support development and quality inspection procedures in pharmaceutical companies.

The software operating environment provides data management to ensure secure information in networked laboratories and enables pharmaceutical companies to comply with regulations and guidelines..

A peak integration algorithm in the software can quantify overlapping peaks more accurately, the company reports. The intelligent peak deconvolution analysis (i-PDeA II), which uses analyte UV spectral information obtained by the PDA detector, has been improved and can be used to show data traces for single components more accurately than with the conventional peak purity method, enabling accurate quantitative values, even for co-eluting peaks.

The software can be used with traditional peak integration methods (Chromatopac mode); the user to select an appropriate peak integration method for the circumstances.

An improved detector function (i-PDeA II) uses differences in the UV absorption spectral patterns of target analytes to separate multiple components that elute at more or less the same time.

Shimadzu

 

 


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.